Drug Pipeline News

Latest News

First gene therapy to treat children with metachromatic leukodystrophu FDA approved | Image Credit: © Calin - © Calin - stock.adobe.com.
First gene therapy to treat children with metachromatic leukodystrophy approved by FDA

March 18th 2024

The decision makes atidarsagene autotemcel the first FDA-approved gene therapy for MLD, a rare genetic disease that affects the brain and nervous system.

FDA approves alirocumab to treat HeFH patients aged 8 years and up | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves alirocumab to treat HeFH patients aged 8 years and up

March 12th 2024

FDA approves Perflutren Lipid Microsphere for pediatric patients with suboptimal echocardiograms | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves Perflutren Lipid Microsphere for pediatric patients with suboptimal echocardiograms

March 4th 2024

Video Interviews
Latest CME Events & Activities

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

Show Me the Data! Navigating FGFR, FGFR Resistance, Immunotherapy, and a World of Clinical Trials in Cholangiocarcinoma Treatment

View More

New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer

View More

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

View More

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

View More

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

View More

2024 USCAP Satellite Symposia

March 25-27, 2024

Register Now!

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

BURST CME™: Taking ALS Management to the Next Level

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

Community Practice Connections™: Guidebook for Community Oncology NSCLC Treating Teams to Administer EGFR Exon 20-Targeted Regimens

View More

Expert Illustrations & Commentaries™: A Closer Look at Emerging Therapies in IBS-C

View More

4th Annual Live Medical Crossfire® IBS and IBD

View More

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

View More

Medical Crossfire®: Optimizing Treatment Sequencing for HR+/HER2- Metastatic Breast Cancer Based on Emerging Evidence and Evolving Algorithms

View More

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

View More

The Latest on Acute Lymphocytic Leukemia

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Show Me the Data: Bridging Clinical Gaps in Later Lines of Metastatic CRC… It’s Easy as VEGFR1, 2, 3!

April 17, 2024

View More

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

New Combination-Based Approaches to Newly Diagnosed MM: What Do the Data, the Experts, and Patients Say?

19 April 2024

Register Now!

Gene Therapy for Hemophilia B—The Next Step Forward in Disease Management

View More

(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

BURST Expert Illustrations & Commentaries™: A Closer Look at the Role of Complement Inhibitors in the Treatment of Paroxysmal Nocturnal Hemoglobinuria

View More

Medical Crossfire®: How Have HER2-Low Expressing Breast Cancers and Novel Advances in the Field Redefined Care As We Knew It?

View More

27th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

More News

© 2024 MJH Life Sciences

All rights reserved.